ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements
Themis Medicare Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report by SAV & Associates LLP confirms adherence to statutory regulations.
Themis Medicare reported Q4 FY26 recovery with ₹76.5cr revenue (up 6.7% YoY) and ₹8.9cr PAT, transitioning from a loss. Strategy focuses on Hospital business growth and API expansion.
Themis Medicare recommended a final dividend of ₹0.5 per equity share for FY 2025-26. Record and meeting dates for shareholder approval will be announced later.
Themis Medicare Ltd reported revenue from operations of ₹76.5 Cr (+6.7% YoY) and net profit of ₹8.9 Cr for Q4 FY26.
Themis Medicare reported audited FY26 financial results and recommended a ₹4.61 Crore final dividend. The board also re-appointed M/s. R. Nanabhoy & Co. as cost auditors.
Themis Medicare scheduled a board meeting for May 28, 2026, to approve FY26 audited financial results. Directors will also consider recommending an equity dividend.
Themis Medicare obtained a Valuation Report and Compliance Certificate for its proposed preferential warrant allotment. These documents support in-principle approval applications filed with stock exchanges.
Themis Medicare Ltd has submitted the RTA compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The registrar, MUFG Intime India, confirmed the processing and listing of dematerialised securities within prescribed timelines.